dopac < dopamine < dopaminergic

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 325.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000100 (2009)	O. K. Sujith [Canada] ; Carol Lane [Canada]	Review: Therapeutic options for continuous dopaminergic stimulation in Parkinson's disease
000139 (2007)	Richard M. Camicioli [Canada] ; Christopher C. Hanstock [Canada] ; Thomas P. Bouchard [Canada] ; Myrlene Gee [Canada] ; Nancy J. Fisher [Canada] ; W. R. Wayne Martin [Canada]	Magnetic resonance spectroscopic evidence for presupplementary motor area neuronal dysfunction in Parkinson's disease
000159 (1993)	Philip Seeman [Canada] ; Hong-Chang Guan [Canada] ; Hubert H. M. Van Tol [Canada] ; Hyman B. Niznik [Canada]	Low density of dopamine D4 receptors in Parkinson's, schizophrenia, and control brain striata
000186 (2008)	Shen-Yang Lim [Canada] ; Andrew H. Evans [Australie] ; Janis M. Miyasaki [Canada]	Impulse Control and Related Disorders in Parkinson's Disease
000231 (1979)	Allan Purdy [Canada] ; Allan Hahn [Canada] ; Henry J. M. Barnett [Canada] ; Paul Bratty [Canada] ; Dildar Ahmad [Canada] ; Kenneth G. Lloyd [Canada] ; Edith G. Mcgeer [Canada] ; Thomas L. Perry [Canada]	Familial fatal parkinsonism with alveolar hypoventilation and mental depression
000238 (2009)	Susan H. Fox [Canada] ; Rosalind Chuang [Canada] ; Jonathan M. Brotchie [Canada]	Serotonin and Parkinson's disease: On movement, mood, and madness
000239 (2012)	Nicola J. Ray [Canada] ; Antonio P. Strafella [Canada]	The neurobiology and neural circuitry of cognitive changes in Parkinson's disease revealed by functional neuroimaging
000291 (1985)	M. Guttman [Canada] ; P. Seeman [Canada]	L-DOPA reverses the elevated density of D2 dopamine receptors in Parkinson's diseased striatum
000313 (1978)	L. Direnfeld [Canada] ; L. Spero [Canada] ; J. Marotta [Canada] ; J. Seeman [Canada]	The L‐dopa on‐off effect in parkinson disease: Treatment by transient drug withdrawal and dopamine receptor resensitization
000378 (2013)	Ji Hyun Ko [Canada] ; Francesca Antonelli [Canada] ; Oury Monchi [Canada] ; Nicola Ray [Canada] ; Pablo Rusjan [Canada] ; Sylvain Houle [Canada] ; Anthony E. Lang [Canada] ; Leigh Christopher [Canada] ; Antonio P. Strafella [Canada]	Prefrontal dopaminergic receptor abnormalities and executive functions in Parkinson's disease
000388 (1998)	Xin-Min Li [Canada] ; Augusto V. Juorio [Canada] ; Jin Qi [Canada] ; Alan A. Boulton [Canada]	Amantadine increases aromatic 1L‐amino acid decarboxylase mRNA in PC12 cells
000410 (2010)	Vesna Sossi [Canada] ; Raul De La Fuente-Fernández [Canada] ; Ramachandiran Nandhagopal [Canada] ; Michael Schulzer [Canada] ; Jessamyn Mckenzie [Canada] ; Thomas J. Ruth [Canada] ; Jan O. Aasly [Norvège] ; Matthew J. Farrer [États-Unis] ; Zbigniew K. Wszolek [États-Unis] ; Jon A. Stoessl [Canada]	Dopamine turnover increases in asymptomatic LRRK2 mutations carriers
000414 (1985)	David Parkinson [Canada] ; Arthur Spira [Canada] ; J. Patrick Wyse [Canada] ; Marilyn Patten [Canada]	The ontogenesis of the dopaminergic cell in the pre- and postnatal guinea pig retina
000416 (1978)	Roger F. Butterworth [Canada] ; Ferdinand Bélanger [Canada] ; André Barbeau [Canada]	Hypokinesia produced by anterolateral hypothalamic 6-hydroxydopamine lesions and its reversal by some antiparkinson drugs
000418 (2003)	Raúl De La Fuente-Fernández [Canada] ; Andrew S. Lim [Canada] ; Vesna Sossi [Canada] ; Michael J. Adam [Canada] ; Thomas J. Ruth [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada] ; Chong S. Lee [Canada]	Age and severity of nigrostriatal damage at onset of Parkinson's disease
000462 (2007)	Vesna Sossi [Canada] ; Raúl De La Fuente-Fernández [Espagne] ; Michael Schulzer [Canada] ; Andre R. Troiano [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada]	Dopamine transporter relation to dopamine turnover in Parkinson's disease: a positron emission tomography study
000465 (2011)	A. Jon Stoessl [Canada] ; David J. Brooks [Royaume-Uni] ; David Eidelberg [États-Unis]	Milestones in neuroimaging
000471 (1988)	C. W. Mcgeer [Canada] ; Shigeru Itagaki [Canada] ; Haruhiko Akiyama [Canada] ; Edith G. Mcgeer [Canada]	Rate of cell death in parkinsonism indicates active neuropathological process
000472 (2012)	S. Al Sweidi [Canada] ; M. G. Sánchez [Canada] ; M. Bourque [Canada] ; M. Morissette [Canada] ; D. Dluzen [États-Unis] ; T. Di Paolo [Canada]	Oestrogen Receptors and Signalling Pathways: Implications for Neuroprotective Effects of Sex Steroids in Parkinson’s Disease
000485 (2007)	Philip Seeman [Canada]	Antiparkinson therapeutic potencies correlate with their affinities at dopamine D2High receptors
000496 (1986)	Mark Guttman [Canada] ; Mark Seeman [Canada] ; Gavin P. Reynolds ; Peter Riederer [Autriche] ; Kurt Jellinger [Autriche] ; Wallace W. Tourtellotte	Dopamine D2 receptor density remains constant in treated Parkinson's disease

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "dopamine" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "dopamine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    dopamine
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022